Free Trial

Phibro Animal Health (PAHC) Competitors

Phibro Animal Health logo
$29.18 -0.26 (-0.88%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$29.41 +0.23 (+0.80%)
As of 07/25/2025 06:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PAHC vs. PCVX, MTSR, CYTK, MRUS, KRYS, AKRO, RNA, ADMA, SRRK, and ACAD

Should you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Vaxcyte (PCVX), Metsera (MTSR), Cytokinetics (CYTK), Merus (MRUS), Krystal Biotech (KRYS), Akero Therapeutics (AKRO), Avidity Biosciences (RNA), ADMA Biologics (ADMA), Scholar Rock (SRRK), and ACADIA Pharmaceuticals (ACAD). These companies are all part of the "pharmaceutical products" industry.

Phibro Animal Health vs. Its Competitors

Vaxcyte (NASDAQ:PCVX) and Phibro Animal Health (NASDAQ:PAHC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Vaxcyte currently has a consensus price target of $136.50, suggesting a potential upside of 272.65%. Phibro Animal Health has a consensus price target of $24.40, suggesting a potential downside of 16.38%. Given Vaxcyte's stronger consensus rating and higher possible upside, research analysts plainly believe Vaxcyte is more favorable than Phibro Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vaxcyte
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.10
Phibro Animal Health
2 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.83

Phibro Animal Health has higher revenue and earnings than Vaxcyte. Vaxcyte is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VaxcyteN/AN/A-$463.93M-$3.99-9.18
Phibro Animal Health$1.02B1.16$2.42M$0.7837.41

Phibro Animal Health has a net margin of 2.68% compared to Vaxcyte's net margin of 0.00%. Phibro Animal Health's return on equity of 30.51% beat Vaxcyte's return on equity.

Company Net Margins Return on Equity Return on Assets
VaxcyteN/A -17.12% -16.26%
Phibro Animal Health 2.68%30.51%6.89%

96.8% of Vaxcyte shares are held by institutional investors. Comparatively, 99.3% of Phibro Animal Health shares are held by institutional investors. 3.1% of Vaxcyte shares are held by company insiders. Comparatively, 50.1% of Phibro Animal Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Vaxcyte has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, Phibro Animal Health has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500.

In the previous week, Vaxcyte had 5 more articles in the media than Phibro Animal Health. MarketBeat recorded 6 mentions for Vaxcyte and 1 mentions for Phibro Animal Health. Vaxcyte's average media sentiment score of 1.66 beat Phibro Animal Health's score of 1.30 indicating that Vaxcyte is being referred to more favorably in the media.

Company Overall Sentiment
Vaxcyte Very Positive
Phibro Animal Health Positive

Summary

Phibro Animal Health beats Vaxcyte on 9 of the 16 factors compared between the two stocks.

Get Phibro Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PAHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PAHC vs. The Competition

MetricPhibro Animal HealthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.19B$10.55B$5.70B$9.50B
Dividend Yield1.63%2.00%4.58%4.00%
P/E Ratio37.4117.3728.3920.08
Price / Sales1.1629.18430.0899.95
Price / Cash13.9323.0336.2258.56
Price / Book4.603.698.675.88
Net Income$2.42M$234.77M$3.25B$258.89M
7 Day Performance-0.78%6.32%4.30%3.70%
1 Month Performance16.16%7.94%10.57%11.71%
1 Year Performance54.56%-13.57%35.68%17.98%

Phibro Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PAHC
Phibro Animal Health
4.0897 of 5 stars
$29.18
-0.9%
$24.40
-16.4%
+55.0%$1.19B$1.02B37.411,940Positive News
PCVX
Vaxcyte
1.7946 of 5 stars
$35.64
-1.6%
$136.50
+283.0%
-56.2%$4.67BN/A-8.93160News Coverage
Positive News
MTSR
Metsera
N/A$39.91
-6.6%
$55.00
+37.8%
N/A$4.49BN/A0.0081Lockup Expiration
Gap Up
CYTK
Cytokinetics
4.145 of 5 stars
$36.96
-0.7%
$70.92
+91.9%
-36.4%$4.45B$18.47M-6.99250News Coverage
MRUS
Merus
1.8941 of 5 stars
$62.37
-1.4%
$84.64
+35.7%
+23.0%$4.38B$54.73M-15.2937Upcoming Earnings
KRYS
Krystal Biotech
4.8912 of 5 stars
$148.09
+0.4%
$213.75
+44.3%
-29.9%$4.26B$290.52M35.60210News Coverage
Analyst Forecast
AKRO
Akero Therapeutics
3.8068 of 5 stars
$51.38
-1.3%
$82.50
+60.6%
+78.5%$4.15BN/A-26.3530Positive News
RNA
Avidity Biosciences
2.1351 of 5 stars
$34.02
+0.8%
$66.35
+95.0%
-18.9%$4.07B$10.90M-11.34190News Coverage
ADMA
ADMA Biologics
3.6012 of 5 stars
$17.13
+2.4%
$27.67
+61.5%
+37.7%$3.99B$426.45M20.15530News Coverage
SRRK
Scholar Rock
3.43 of 5 stars
$41.12
+1.0%
$42.67
+3.8%
+312.2%$3.87B$33.19M-16.25140Positive News
ACAD
ACADIA Pharmaceuticals
4.1503 of 5 stars
$22.28
-1.2%
$27.88
+25.1%
+25.3%$3.78B$996.28M16.26510Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:PAHC) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners